Dismay over MS treatment decision
Multiple sclerosis charities have said they are "bitterly disappointed" at a decision not to prescribe an anti-MS drug in Scotland. Both the MS Society and the MS Trust believe the drug Tysabri could help slow the progression of disability in hundreds of sufferers. But the Scottish Medicines Consortium said the economic case for the drug had not been demonstrated. The charities urged sufferers to fight for Tysabri on an individual basis.